Molina Healthcare diskutieren

Molina Healthcare, Inc. (NYSE: MOH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $406.00 price target on the stock.

Hey there! I've been keeping an eye on Molina Healthcare, and I've got to say, I'm pretty bullish on this one. Their stock has been on a nice little run lately, up over 15% in the past three months. Not too shabby, right? What's got me excited is their growing customer base, especially in Medicaid and Medicare. It's like they've found the secret sauce for attracting new members. And let's not forget about those juicy contract wins in Florida and Michigan. Talk about expanding your reach! Now, I know what you're thinking - what about those rising medical costs? Yeah, that's a bit of a fly in the ointment. But here's the thing: Molina seems to have a knack for managing their finances well. They've got a solid cash reserve and strong cash flow generation. It's like they've built themselves a nice financial fortress. Looking ahead, analysts are projecting some pretty sweet earnings growth. We're talking about a potential 12.6% jump in 2024 and another 12.9% in 2025. It's like Molina's playing chess while others are playing checkers. Sure, there are some risks to keep in mind. That rising medical care ratio isn't ideal. But when I weigh everything up - the growth potential, the solid financials, the market position - I can't help but feel optimistic. At the current price of $311.5, I think there's still room for this stock to run. My target price is $340. It's not going to shoot to the moon overnight, but I reckon it's got some good upside potential. Just remember, I'm not a financial advisor - this is just my take on things. Always do your own research before making any investment decisions!

Molina Healthcare, Inc. (NYSE: MOH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $406.00 price target on the stock.

Molina Healthcare, Inc. (NYSE: MOH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Molina Healthcare, Inc. (NYSE: MOH) had its price target lowered by analysts at Robert W. Baird from $405.00 to $331.00. They now have an "outperform" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $406.00 price target on the stock.

Molina Healthcare, Inc. (NYSE: MOH) had its price target lowered by analysts at Truist Financial Co. from $400.00 to $370.00. They now have a "buy" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.

Molina Healthcare, Inc. (NYSE: MOH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.

Molina Healthcare, Inc. (NYSE: MOH) had its price target lowered by analysts at Truist Financial Co. from $370.00 to $340.00. They now have a "buy" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) had its price target lowered by analysts at Mizuho from $382.00 to $376.00. They now have an "outperform" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $372.00 price target on the stock, up previously from $295.00.

Molina Healthcare, Inc. (NYSE: MOH) had its price target raised by analysts at Mizuho from $376.00 to $400.00. They now have an "outperform" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) had its price target raised by analysts at Truist Financial Co. from $340.00 to $400.00. They now have a "buy" rating on the stock.

Molina Healthcare, Inc. (NYSE: MOH) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $364.00 price target on the stock.

Molina Healthcare, Inc (NYSE: MOH) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.

Molina Healthcare, Inc (NYSE: MOH) had its price target lowered by analysts at Mizuho from $400.00 to $330.00. They now have an "outperform" rating on the stock.

Molina Healthcare, Inc (NYSE: MOH) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $335.00. They now have a "buy" rating on the stock.

Molina Healthcare, Inc (NYSE: MOH) had its price target lowered by analysts at Wells Fargo & Company from $372.00 to $216.00. They now have an "overweight" rating on the stock.

Molina Healthcare, Inc (NYSE: MOH) had its price target lowered by analysts at Wells Fargo & Company from $216.00 to $198.00. They now have an "overweight" rating on the stock.